Association Between Intrauterine Growth Restriction and Chronic Kidney Disease: A Birth Cohort Study Analysis

Daniela Aparecida Lorencini1, Paulo Cesar Lopes1, Heloísa Bettiol2

  • 1Internal Medicine Department, Ribeirao Preto Medical School, University of Sao Paulo, Brazil.

Kidney Medicine
|November 10, 2025
PubMed

Insights

Intrauterine growth restriction (IUGR) increases chronic kidney disease (CKD) risk, especially in women. Low birth weight and prematurity did not show significant associations with CKD risk in this birth cohort study.

Area of Science:

  • Nephrology
  • Developmental Biology
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a major health concern, with diabetes and hypertension as primary risk factors.
  • Fetal development factors, including low birth weight (LBW), intrauterine growth restriction (IUGR), and prematurity, are increasingly recognized as contributors to later-life kidney function decline.
  • Understanding the long-term impact of these birth-related conditions is crucial for early intervention and prevention strategies.

Purpose of the Study:

  • To investigate the association between fetal growth conditions (IUGR, LBW, prematurity) and the risk of developing CKD by the third decade of life.
  • To evaluate the impact of these birth exposures on kidney function markers, specifically estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio (UACR).

Main Methods:

  • A single-center birth cohort study was conducted in Brazil, enrolling 6,827 newborns between 1978-1979.
  • Follow-up data from 1,564 participants in 2016-2017 were analyzed.
  • Statistical models, including multivariable linear regression, quantile regression, and logistic regression, were used to assess the relationship between birth exposures and CKD outcomes.

Main Results:

  • Intrauterine growth restriction (IUGR) was significantly associated with a higher prevalence of CKD (25.3% vs 18.1%) and increased CKD risk (OR 1.50 [1.10-2.21]).
  • Prematurity was linked to a slightly lower eGFR, but neither LBW nor prematurity showed a significant association with CKD risk in multivariate analysis.
  • Factors like female sex, high blood pressure, diabetes mellitus, and elevated C-reactive protein levels were associated with increased CKD risk or poorer kidney function markers.

Conclusions:

  • Intrauterine growth restriction (IUGR) is a significant risk factor for developing chronic kidney disease (CKD) later in life, particularly in females.
  • While prematurity and LBW were not directly linked to increased CKD risk in this cohort, IUGR highlights the critical role of fetal development in long-term kidney health.
  • These findings underscore the importance of monitoring individuals with a history of IUGR for kidney function.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
791
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
407
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537